Researchers Say Women Should Not Receive Hip Resurfacing; Regulatory Lessons Cited
This article was originally published in The Gray Sheet
Executive Summary
A major study in The Lancet finds "unacceptably high" revision rates among women who had hip resurfacing.
You may also be interested in...
Metal-On-Metal Hips Get Failing Grade In New Registry Analysis
Devices were linked to a notably higher five-year revision rate compared to metal-on-polyethylene or ceramic-on-ceramic hips in an analysis of more than 400,000 implants. Recalled J&J/DePuy ASR devices were not included in the analysis.
J&J/DePuy Recalls ASR Hip Systems - Effort Could Cost $1.2 Bil.
Johnson & Johnson subsidiary DePuy Orthopaedics is recalling all of its ASR hip resurfacing and ASR XL acetabular hip replacement systems worldwide due to elevated rates of revision surgeries to replace the devices, the company said Aug. 26
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.